---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-067520"
form_type: "8-K"
ticker: "OKUR"
cik: "0001637715"
company_name: "OnKure Therapeutics, Inc."
filed_at: "2023-03-10T23:59:59+00:00"
generated_at: "2026-06-18T05:32:10.788158+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Reneo Pharmaceuticals says SVB exposure immaterial; accounts hold minimal cash

## Summary
- Company maintains operating accounts at Silicon Valley Bank with minimal cash relative to total cash, cash equivalents and investments.
- Believes any loss from SVB receivership is immaterial to its financial position.
- No further details on total cash balance or contingency plans disclosed.

## SEC filing metadata
- accession: 0001193125-23-067520
- form_type: 8-K
- ticker: OKUR
- cik: 0001637715
- company_name: OnKure Therapeutics, Inc.
- filed_at: 2023-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1637715/000119312523067520/0001193125-23-067520-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1637715/000119312523067520/d481495d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-067520
- JSON: https://secwatch.observer/filing/0001193125-23-067520.json
- Plain text: https://secwatch.observer/filing/0001193125-23-067520.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.